May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
First-in-Human PIIO-1 Trial for Recurrent Glioblastoma Receives IND Approval – Pelotonia Institute for Immuno-Oncology
Apr 13, 2025, 14:44

First-in-Human PIIO-1 Trial for Recurrent Glioblastoma Receives IND Approval – Pelotonia Institute for Immuno-Oncology

Pelotonia Institute for Immuno-Oncology shared a post on X:

“We’re celebrating IND approval for the first in human PIIO-1 trial — a groundbreaking CAR-T Cell Therapy for recurrent glioblastoma!

This novel approach targets GARP and delivers engineered T cells directly into the tumor.

A major milestone for GBM research and immunotherapy!”

More posts featuring Pelotonia Institute for Immuno-Oncology.